Clinical Trials on Neoplasms, Neuroepithelial

Total 107685 results

Groupe Hospitalier Pitie-Salpetriere

Completed

cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study (ARBITRAGE)

Arrhythmias, Cardiac | Tachycardia, Supraventricular | Cardiac Failure | Atrial Fibrillation and Flutter

France
Vanderbilt University

Terminated

Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure

Hypertension | Multiple System Atrophy | Pure Autonomic Failure

United States
Azienda ULSS 5 Polesana
University of Padova

Unknown

A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction (IM-ADHERENCE)

Myocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)

Italy
University of Zurich

Completed

Exercise Effects in Huntington's Disease

Huntington's Disease

Switzerland
Susan J. Hayflick
Oregon Health and Science University; Oregon Clinical and Translational Research...

Completed

Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)

Pantothenate Kinase-associated Neurodegeneration (PKAN)

United States
Assistance Publique - Hôpitaux de Paris

Completed

Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride (NEUROHD)

Huntington Disease

France
Pfizer

Completed

Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease

Huntington's Disease

France
Ohio State University
Lundbeck LLC

Completed

Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease

Huntington's Disease

United States
Pfizer

Completed

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

Huntington's Disease

United States, Germany, United Kingdom, Canada, Poland
Assistance Publique - Hôpitaux de Paris

Completed

MIG-HD: Multicentric Intracerebral Grafting in Huntington's Disease (MIG-HD)

Huntington Disease

France
Jae-Kwan Song

Unknown

Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO)

Patent Foramen Ovale

Korea, Republic of
GlaxoSmithKline

Completed

Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease

Huntington Disease

United Kingdom
GlaxoSmithKline

Completed

A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278

Huntington Disease

Netherlands
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Unknown

Beta Testing of a New Assessment in Huntington's Disease (HD) (CAPIT-HD Beta)

Huntington Disease

France
Biogen

Completed

A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis (MOTION - JAPAN)

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent Progressive

Japan
Institut National de la Santé Et de la Recherche...

Completed

Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease (PRO-MH2)

Huntington Disease

France
Vanderbilt University

Terminated

Magnetic Resonance Spectroscopy in Autonomic Failure

Multiple System Atrophy | Pure Autonomic Failure

United States
University of California, Davis

Completed

A Pre-Cellular Therapy Observational Study in Early Huntington's Disease (PRE-CELL)

Huntington Disease

United States
Palobiofarma SL
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Terminated

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-999 "After Multiple Oral Doses" in Healthy Volunteers

Huntington Disease

Spain
University of Rochester
Kaneka Corporation

Completed

Bioavailability of Ubiquinol in Huntington Disease

Huntington Disease

United States
Massachusetts General Hospital
National Center for Complementary and Integrative Health (NCCIH); University...

Terminated

Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) (CREST-E)

Huntington's Disease

United States, Canada, New Zealand, Australia
Taipei Medical University WanFang Hospital

Completed

To Study Polycystic Ovary Syndrome in Taiwanese Women

Cardiovascular Disease | Polycystic Ovary Syndrome | Metabolic Syndrome

Taiwan
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., Japan

Completed

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

Polycystic Ovarian Syndrome | Anovulation | Oligo-ovulation | Hypothalamic-pituitary Dysfunction

Japan
Children's Oncology Group
National Cancer Institute (NCI)

Withdrawn

Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder

Leukemia
Psyadon Pharma

Completed

Ecopipam Treatment of Tourette Syndrome

Tourette's Syndrome

United States
Universitaire Ziekenhuizen KU Leuven

Unknown

Functional Imaging of Social Cognition in Premanifest Huntington's Disease (FISCIP)

Huntington's Disease
Medivation, Inc.
Huntington Study Group

Completed

A Study of the Novel Drug Dimebon in Patients With Huntington's Disease (DIMOND)

Huntington's Disease

United States
Ron Postuma
Canadian Institutes of Health Research (CIHR); University of Toronto

Completed

Caffeine for Excessive Daytime Somnolence in Parkinson's Disease

Parkinson's Disease | Excessive Daytime Somnolence

Canada
McMaster University
Pfizer; Hamilton Health Sciences Corporation

Terminated

Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study) (PREGA)

Complex Regional Pain Syndromes

Canada
Teva Branded Pharmaceutical Products R&D, Inc.
H. Lundbeck A/S

Completed

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Multiple System Atrophy

United States, Austria, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Portugal, Spain, United Kingdom
Charite University, Berlin, Germany
University Hospital Muenster; Ruhr University of Bochum; University of Ulm

Completed

Apathy Cure Through Bupropion in Huntington's Disease (Action-HD)

Huntington's Disease | Apathy

Germany
National Institute of Neurological Disorders and...

Terminated

Augmenting Effects of L-DOPS With Carbidopa and Entacapone

Parkinson Disease | Autonomic Nervous System Diseases | Multiple System Atrophy

United States
GTx

Completed

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Cachexia

United States, Canada
Laval University
Canadian Diabetes Association; Diabetes Québec; Institute of Nutraceuticals and...

Completed

Assessment of Cod Protein as an Insulin-sensitizing Agent in Women With Polycystic Ovary Syndrome. (PCOS)

Polycystic Ovarian Syndrome | Insulin Sensitivity

Canada
Seoul St. Mary's Hospital

Unknown

Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy

Lymphoma | Chronic Hepatitis B
Unither Pharmaceuticals, France

Completed

A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study (NIAGARA)

Head and Neck Cancer | Xerostomia | Hyposalivation | Sjögren Syndrome

France
Milton S. Hershey Medical Center
National Cancer Institute (NCI)

Unknown

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Cancer

United States
AbbVie (prior sponsor, Abbott)
North America Pediatric Renal Trials and Collaborative Studies (NAPRTCS)

Terminated

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

End-Stage Renal Disease | Secondary Hyperparathyroidism

United States
Siena Biotech S.p.A.

Completed

A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease

Huntington's Disease

United States
Assy Nimer

Unknown

THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOS

Nonalcoholic Fatty Liver Disease | Polycystic Ovarian Syndrome,

Israel
Heinrich-Heine University, Duesseldorf

Completed

Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease

Huntington's Disease

Germany
Kyowa Kirin Co., Ltd.

Completed

Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease (MBD-5D)

End Stage Renal Disease | Hyperparathyroidism, Secondary

Japan
Henri Mondor University Hospital

Completed

Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia (HCQITP)

Systemic Lupus Erythematosus | Immune Thrombocytopenia
Seoul National University Hospital
European Huntington's Disease Network

Unknown

Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)

Huntington Disease

Korea, Republic of
Siena Biotech S.p.A.

Completed

Escalating Dose Study in Healthy Volunteers With SEN0014196

Huntington's Disease

United Kingdom
University of Rochester

Completed

Effects of Music Therapy on Huntington's Disease

Huntington's Disease

United States
Yonsei University

Completed

Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy

Multiple System Atrophy

Korea, Republic of
HP Therapeutics Foundation
Huntington Study Group

Unknown

Cooperative Huntington's Observational Research Trial

Huntington Disease

United States, Canada, Australia
Johns Hopkins University

Terminated

Pilot Study of the Modified Atkins Diet for Tourette Syndrome

Tourette Syndrome

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Cancer

United States

Clinical Trials on Neoplasms, Neuroepithelial

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations